Clinical Trials Browser

Esophageal Neoplasms × Caloric Restriction × Clear all

NCT03676478 2025-12-10

EFECTS

Phase NA Terminated

Gastrointestinal

Esophageal Neoplasms, Postoperative Complications, Muscle Weakness, Sarcopenia